Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice

Area of Science:

• Immunology
• Molecular Biology
• Developmental Biology

Background:

• gp39 (also known as T-cell costimulatory molecule) and its receptor CD40 are crucial for T-cell mediated immunity.
• The role of gp39 and CD40 in the thymus, the primary site of T-cell development, is not well understood.

Purpose of the Study:

• To investigate the function of gp39 in the thymus and its potential role in immune regulation and disease pathogenesis.
• To elucidate the consequences of gp39 overexpression on thymocyte development and peripheral immune responses.

Main Methods:

• Generation of transgenic mice overexpressing gp39 in a dose-dependent manner.
• Analysis of thymocyte populations, thymic architecture, and peripheral lymphoid tissues.
• Bone marrow transplantation experiments to assess the impact of gp39 in a normal thymic environment.

Main Results:

• Overexpression of gp39 in the thymus led to a significant reduction in thymocyte numbers, loss of cortical epithelium, and expansion of CD40+ medullary cells.
• Transplanted bone marrow from transgenic mice resulted in decreased thymocyte viability.
• Peripheral tissues exhibited inflammation and lymphoid tissue hypertrophy, with high transgene copy numbers causing lethal inflammatory bowel disease.

Conclusions:

• gp39 plays a critical regulatory role in thymus function.
• gp39 overexpression can lead to immune system defects and chronic inflammatory diseases, partly due to impaired intracellular sequestration mechanisms.
• These findings highlight a novel link between gp39, thymic regulation, and the development of inflammatory conditions.